Literature DB >> 22282525

Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Sarah-Jane Watson1, Alastair J H Brown, Nicholas D Holliday.   

Abstract

GPR120 is a long-chain fatty acid receptor that stimulates incretin hormone release from colonic endocrine cells and is implicated in macrophage and adipocyte function. The functional consequences of long (L) and short (S) human GPR120 splice variants, which differ by insertion of 16 amino acids in the third intracellular loop, are currently unknown. Here we compare signaling and intracellular trafficking of GPR120S and GPR120L receptors, using calcium mobilization and dynamic mass redistribution (DMR) assays, together with quantitative imaging measurements of β-arrestin2 association and receptor internalization. FLAG- or SNAP-tagged GPR120S receptors elicited both intracellular calcium mobilization and DMR responses in human embryonic kidney 293 cells, when stimulated with oleic acid, myristic acid, or the agonist 4-[[(3-phenoxyphenyl)methyl]amino]benzenepropanoic acid (GW9508). Responses were insensitive to pertussis toxin, but increases in intracellular calcium were attenuated by 2-aminoethoxydiphenyl borate, an inhibitor of store inositol trisphosphate receptors. Despite equivalent cell surface expression of SNAP-tagged GPR120L receptors, no specific calcium or DMR responses were observed in cells transfected with this isoform. However, agonist-stimulated GPR120S and GPR120L receptors both recruited β-arrestin2 and underwent robust internalization, with similar agonist potencies in each case. After oleic acid-induced internalization, neither GPR120 isoform recycled rapidly to the cell surface. In both cases, confocal microscopy indicated receptor targeting to lysosomal compartments. Thus, the third intracellular loop insertion in GPR120L prevents G protein-dependent intracellular calcium and DMR responses, but this receptor isoform remains functionally coupled to the β-arrestin pathway, providing one of the first examples of a native β-arrestin-biased receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282525      PMCID: PMC3336805          DOI: 10.1124/mol.111.077388

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.

Authors:  J Sakamoto; H Kimura; S Moriyama; H Odaka; Y Momose; Y Sugiyama; H Sawada
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

2.  Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives.

Authors:  Robert Fredriksson; Pär J Höglund; David E I Gloriam; Malin C Lagerström; Helgi B Schiöth
Journal:  FEBS Lett       Date:  2003-11-20       Impact factor: 4.124

3.  Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.

Authors:  Kerstin Wirkner; Joana Schweigel; Zoltan Gerevich; Heike Franke; Clemens Allgaier; Edward Leon Barsoumian; Henning Draheim; Peter Illes
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

4.  A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.

Authors:  Knut Kotarsky; Niclas E Nilsson; Erik Flodgren; Christer Owman; Björn Olde
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

5.  A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity.

Authors:  Susan E Senogles; Tamra L Heimert; Emilia Riviera Odife; Michael W Quasney
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

6.  Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis.

Authors:  S Cotecchia; J Ostrowski; M A Kjelsberg; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

7.  Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.

Authors:  Yasuaki Itoh; Yuji Kawamata; Masataka Harada; Makoto Kobayashi; Ryo Fujii; Shoji Fukusumi; Kazuhiro Ogi; Masaki Hosoya; Yasuhiro Tanaka; Hiroshi Uejima; Hideyuki Tanaka; Minoru Maruyama; Rie Satoh; Shoichi Okubo; Hideki Kizawa; Hidetoshi Komatsu; Fumika Matsumura; Yuko Noguchi; Tokuyuki Shinohara; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  Nature       Date:  2003-02-23       Impact factor: 49.962

8.  GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

Authors:  Da Young Oh; Saswata Talukdar; Eun Ju Bae; Takeshi Imamura; Hidetaka Morinaga; WuQiang Fan; Pingping Li; Wendell J Lu; Steven M Watkins; Jerrold M Olefsky
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

9.  The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.

Authors:  Celia P Briscoe; Mohammad Tadayyon; John L Andrews; William G Benson; Jon K Chambers; Michelle M Eilert; Catherine Ellis; Nabil A Elshourbagy; Aaron S Goetz; Dana T Minnick; Paul R Murdock; Howard R Sauls; Usman Shabon; Lisa D Spinage; Jay C Strum; Philip G Szekeres; Kong B Tan; James M Way; Diane M Ignar; Shelagh Wilson; Alison I Muir
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

Review 10.  Fatty acid metabolism and insulin secretion in pancreatic beta cells.

Authors:  G C Yaney; B E Corkey
Journal:  Diabetologia       Date:  2003-09-12       Impact factor: 10.122

View more
  46 in total

Review 1.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

2.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

3.  Luciferase Complementation Approaches to Measure GPCR Signaling Kinetics and Bias.

Authors:  Nicola C Dijon; Desislava N Nesheva; Nicholas D Holliday
Journal:  Methods Mol Biol       Date:  2021

4.  Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Authors:  Ilya S Senatorov; Ameneh Cheshmehkani; Rebecca N Burns; Kirti Singh; Nader H Moniri
Journal:  Mol Pharmacol       Date:  2020-03-04       Impact factor: 4.436

Review 5.  Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

Authors:  G Milligan; E Alvarez-Curto; K R Watterson; T Ulven; B D Hudson
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

Review 8.  ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.

Authors:  Timothy D O'Connell; Robert C Block; Shue P Huang; Gregory C Shearer
Journal:  J Mol Cell Cardiol       Date:  2016-12-14       Impact factor: 5.000

9.  Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages.

Authors:  Ameneh Cheshmehkani; Ilya S Senatorov; Jyothi Dhuguru; Ola Ghoneim; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2017-09-21       Impact factor: 5.858

10.  Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.

Authors:  Ze Liu; Mandi M Hopkins; Zhihong Zhang; Chrystal B Quisenberry; Louise C Fix; Brianna M Galvan; Kathryn E Meier
Journal:  J Pharmacol Exp Ther       Date:  2014-12-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.